×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARGX – argenx se - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARGX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
09:58 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $639.00 to $723.00. They now have an "overweight" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Wells Fargo & Company from $639.00 to $723.00. They now have an "overweight" rating on the stock.
12/9
09:22 am
argx
Should You Increase Your Holdings in argenx SE (ARGX)? [Yahoo! Finance]
Low
Report
Should You Increase Your Holdings in argenx SE (ARGX)? [Yahoo! Finance]
12/3
10:14 am
argx
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $655.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $655.00 price target on the stock.
12/2
03:10 pm
argx
Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
Low
Report
Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
11/26
01:00 am
argx
argenx to Present at Upcoming Investor Conferences
Low
Report
argenx to Present at Upcoming Investor Conferences
11/21
10:20 am
argx
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $675.00 price target on the stock, up previously from $646.00.
Low
Report
argenx SE (NASDAQ: ARGX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $675.00 price target on the stock, up previously from $646.00.
11/21
09:00 am
argx
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Evercore ISI from $675.00 to $706.00. They now have an "outperform" rating on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its price target raised by analysts at Evercore ISI from $675.00 to $706.00. They now have an "outperform" rating on the stock.
11/20
01:16 pm
argx
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $617.00 price target on the stock.
Low
Report
argenx SE (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $617.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
10/31/2024
02:00 am
argx
argenx se - american depositary shares
BEAT
Report
7.0%
argenx se - american depositary shares
7/25/2024
01:00 am
argx
argenx se - american depositary shares
BEAT
Report
35.1%
argenx se - american depositary shares
5/9/2024
01:00 am
argx
argenx se - american depositary shares
MISS
Report
-5.6%
argenx se - american depositary shares
2/29/2024
01:00 am
argx
argenx se - american depositary shares
MISS
Report
-7.7%
argenx se - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
01:24 pm
argx
Form SC 13G/A ARGENX SE Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Low
Report
Form SC 13G/A ARGENX SE Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/12
09:59 am
argx
Form SC 13G/A ARGENX SE Filed by: FMR LLC
Low
Report
Form SC 13G/A ARGENX SE Filed by: FMR LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/12
argenx announces closing of global offering
7.2%
8/6 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.4%
3/4 argenx SE - (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at Nomura. They now have a $255.00 price target on the stock. 4.4%
10/1 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 4.1%
5/23 argenx SE - (NASDAQ: ARGX) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $182.00 price target on the stock, up previously from $161.00. 3.6%
5/15 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.5%
6/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 2.8%
12/9 Form 6-K ARGENX SE For: Dec 07 2.7%
6/18 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.6%
10/24 argenx reports third quarter 2019 financial results and provides business update 2.6%
8/6 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.4%
3/4 argenx SE - (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at Nomura. They now have a $255.00 price target on the stock. 4.4%
10/1 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 4.1%
5/23 argenx SE - (NASDAQ: ARGX) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $182.00 price target on the stock, up previously from $161.00. 3.6%
5/15 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.5%
6/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 2.8%
12/9 Form 6-K ARGENX SE For: Dec 07 2.7%
6/18 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.6%
10/24 argenx reports third quarter 2019 financial results and provides business update 2.6%
TOP News Decliners
2/27
Form 6-K ARGENX SE For: Feb 27
-5.7%
9/9 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.7%
1/13 Form 6-K ARGENX SE For: Jan 13 -4.7%
5/22 Form 6-K ARGENX SE For: May 22 -4.7%
5/9 Form 6-K ARGENX SE For: May 09 -3.5%
3/31 Form 20-F ARGENX SE For: Dec 31 -3.3%
6/25 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $156.00 price target on the stock. -3.0%
1/22 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $172.00 price target on the stock. -2.8%
9/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Wells Fargo & Co. They set a "market perform" rating on the stock. -2.7%
9/3 argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference -2.5%
9/9 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.7%
1/13 Form 6-K ARGENX SE For: Jan 13 -4.7%
5/22 Form 6-K ARGENX SE For: May 22 -4.7%
5/9 Form 6-K ARGENX SE For: May 09 -3.5%
3/31 Form 20-F ARGENX SE For: Dec 31 -3.3%
6/25 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $156.00 price target on the stock. -3.0%
1/22 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $172.00 price target on the stock. -2.8%
9/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Wells Fargo & Co. They set a "market perform" rating on the stock. -2.7%
9/3 argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: